Researching innovations in drug development that aim to improve outcomes and quality of life for patients
We work in serious conditions where the physical and social impacts on patients and their families are great. Our team of experts understands the physical and emotional effects of these diseases. In fact, it’s what drives us every day to conduct clinical trials with the individual in mind.
Driving Successful Outcomes Through Engagement
We’re committed to working with patients, partners, and stakeholders, employing trial designs that aim to bring substantive solutions to improve quality of life for patients and their families. We build relationships with patient advocacy groups, constantly striving to better understand the needs of patients and their families.
We’re Working in Rare Diseases
Currently, we are working closely with mucopolysaccharidosis II (MPS II, Hunter syndrome) patients and clinicians on a patient-focused clinical trial that expedites a solution to the unmet medical need in this rare and life-limiting condition.
Read more on MPS II
Our Approach to Clinical Trials
We employ creative trial designs based on sound scientific principles to accelerate our clinical trials and promote successful outcomes.
Actigen proposes to demonstrate the benefits of GNR-055 to patients across the spectrum of disease through our approach to clinical trial design.
In our clinical trials
- We consider the needs of the individual patients and their families
- We employ inventive designs to expedite our trials
